miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis

Background and aims: Systemic sclerosis (SSc) is a common autoimmune disorder involving the skin, blood vessels, and internal organs with an elusive pathophysiology. SSc is believed to be a genetically prone T-cell-mediated autoimmune disease. miRNAs and lncRNAs were thought to be involved in the et...

Full description

Bibliographic Details
Main Authors: Ahmed MB. Khedr, Olfat G. Shaker, Mohamed HM. EL-Komy, Amul M. Badr, Randa Erfan
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-03-01
Series:Non-coding RNA Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468054023000951
_version_ 1797267196969222144
author Ahmed MB. Khedr
Olfat G. Shaker
Mohamed HM. EL-Komy
Amul M. Badr
Randa Erfan
author_facet Ahmed MB. Khedr
Olfat G. Shaker
Mohamed HM. EL-Komy
Amul M. Badr
Randa Erfan
author_sort Ahmed MB. Khedr
collection DOAJ
description Background and aims: Systemic sclerosis (SSc) is a common autoimmune disorder involving the skin, blood vessels, and internal organs with an elusive pathophysiology. SSc is believed to be a genetically prone T-cell-mediated autoimmune disease. miRNAs and lncRNAs were thought to be involved in the etiology of several immunological diseases including SSc. This work aimed to assess the expression of miRNA-133, lncRNA-H19, PKM2, and TGF-β levels in SSc in comparison to controls and their relationship to the clinical course and severity of disease. Patients and methods: Fifty patients with SSc and 40 healthy age and sex-matched controls were included in this study. miRNA-133 and H19 expression levels were detected using quantitative RT-PCR while serum levels of PKM2 and TGF-β were measured using ELISA techniques. Patients’ clinical data and treatments received were extracted and correlated with proteins investigated. Results: Our results showed that miRNA-133 was significantly downregulated in SSc patients in comparison to controls (Mean + SD of SSc = 0.61 ± 0.22, Mean ± SD of HC = 0.97 ± 0.007, p = 0.003). However, there was significant upregulation of the serum expressions of all other tested biomarkers in SSc patients in comparison to controls; H19 (Mean + SD of SSc = 10.37 ± 3.13, Mean ± SD of HC = 1.01 ± 0.01, p = 0.0001), PKM2 (Mean + SD of SSc = 28.0 ± 4.84, Mean ± SD of HC = 16.19 ± 1.32, p = 0.005) and TGF-β (Mean + SD of SSc = 150.8 ± 6.36, Mean ± SD of HC = 23.83 ± 0.93, p = 0.0001). We also detected several correlations between serum levels of the investigated proteins in patients with SSc. Conclusion: Along with TGF-β, our results show that miRNA-133, H19, and PKM2 seem to be potential contributors to SSc pathogenesis and could be promising biomarkers in the diagnosis of SSc patients. The lncRNA-H19 correlations with TGF- β, miRNA-133, and PKM2 suggest a possible influential effect of this RNA molecule on the pathogenesis of SSc.
first_indexed 2024-03-08T19:58:24Z
format Article
id doaj.art-a3a9edbc1cd040bb94d73aa660d9c469
institution Directory Open Access Journal
issn 2468-0540
language English
last_indexed 2024-04-25T01:12:45Z
publishDate 2024-03-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Non-coding RNA Research
spelling doaj.art-a3a9edbc1cd040bb94d73aa660d9c4692024-03-10T05:12:31ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402024-03-0191253261miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosisAhmed MB. Khedr0Olfat G. Shaker1Mohamed HM. EL-Komy2Amul M. Badr3Randa Erfan4Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Helwan University, Ain Helwan, Cairo, Egypt; Corresponding author.Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, EgyptDermatology Department, Faculty of Medicine, Cairo University, Cairo, EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, EgyptDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, EgyptBackground and aims: Systemic sclerosis (SSc) is a common autoimmune disorder involving the skin, blood vessels, and internal organs with an elusive pathophysiology. SSc is believed to be a genetically prone T-cell-mediated autoimmune disease. miRNAs and lncRNAs were thought to be involved in the etiology of several immunological diseases including SSc. This work aimed to assess the expression of miRNA-133, lncRNA-H19, PKM2, and TGF-β levels in SSc in comparison to controls and their relationship to the clinical course and severity of disease. Patients and methods: Fifty patients with SSc and 40 healthy age and sex-matched controls were included in this study. miRNA-133 and H19 expression levels were detected using quantitative RT-PCR while serum levels of PKM2 and TGF-β were measured using ELISA techniques. Patients’ clinical data and treatments received were extracted and correlated with proteins investigated. Results: Our results showed that miRNA-133 was significantly downregulated in SSc patients in comparison to controls (Mean + SD of SSc = 0.61 ± 0.22, Mean ± SD of HC = 0.97 ± 0.007, p = 0.003). However, there was significant upregulation of the serum expressions of all other tested biomarkers in SSc patients in comparison to controls; H19 (Mean + SD of SSc = 10.37 ± 3.13, Mean ± SD of HC = 1.01 ± 0.01, p = 0.0001), PKM2 (Mean + SD of SSc = 28.0 ± 4.84, Mean ± SD of HC = 16.19 ± 1.32, p = 0.005) and TGF-β (Mean + SD of SSc = 150.8 ± 6.36, Mean ± SD of HC = 23.83 ± 0.93, p = 0.0001). We also detected several correlations between serum levels of the investigated proteins in patients with SSc. Conclusion: Along with TGF-β, our results show that miRNA-133, H19, and PKM2 seem to be potential contributors to SSc pathogenesis and could be promising biomarkers in the diagnosis of SSc patients. The lncRNA-H19 correlations with TGF- β, miRNA-133, and PKM2 suggest a possible influential effect of this RNA molecule on the pathogenesis of SSc.http://www.sciencedirect.com/science/article/pii/S2468054023000951Systemic sclerosismiRNA-133lncRNA H19PKM2TGF-β
spellingShingle Ahmed MB. Khedr
Olfat G. Shaker
Mohamed HM. EL-Komy
Amul M. Badr
Randa Erfan
miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis
Non-coding RNA Research
Systemic sclerosis
miRNA-133
lncRNA H19
PKM2
TGF-β
title miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis
title_full miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis
title_fullStr miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis
title_full_unstemmed miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis
title_short miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis
title_sort mirna 133 and lncrna h19 expressions and their relation to serum levels of pkm2 and tgf β in patients with systemic sclerosis
topic Systemic sclerosis
miRNA-133
lncRNA H19
PKM2
TGF-β
url http://www.sciencedirect.com/science/article/pii/S2468054023000951
work_keys_str_mv AT ahmedmbkhedr mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis
AT olfatgshaker mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis
AT mohamedhmelkomy mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis
AT amulmbadr mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis
AT randaerfan mirna133andlncrnah19expressionsandtheirrelationtoserumlevelsofpkm2andtgfbinpatientswithsystemicsclerosis